What pharmacologists can learn from recent advances in estrogen signalling
- 30 September 2003
- journal article
- review article
- Published by Elsevier
- Vol. 24 (9) , 479-485
- https://doi.org/10.1016/s0165-6147(03)00229-3
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New AgentsJournal of Medicinal Chemistry, 2003
- Expression Of Estrogen Receptors α And β By Sympathetic Ganglion Neurons Projecting To The Proximal Urethra Of Female RatsJournal of Urology, 2003
- Involvement of estrogen receptor β in terminal differentiation of mammary gland epitheliumProceedings of the National Academy of Sciences, 2002
- Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene ExpressionJournal of Biological Chemistry, 2002
- Tamoxifen effects on subjective and psychosexual well-being, in a randomised breast cancer study comparing high-dose and standard-dose chemotherapyBritish Journal of Cancer, 2002
- Estrogen receptor beta in breast cancer.Endocrine-Related Cancer, 2002
- 4-Hydroxytamoxifen Trans-Represses Nuclear Factor- B Activity in Human Osteoblastic U2-OS Cells through Estrogen Receptor (ER) , and Not through EREndocrinology, 2001
- Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 SitesScience, 1997
- Agonistic Effect of Tamoxifen Is Dependent on Cell Type, ERE-Promoter Context, and Estrogen Receptor Subtype: Functional Difference between Estrogen Receptors α and βBiochemical and Biophysical Research Communications, 1997
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996